English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, April 26, 2024
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Wednesday, March 27, 2024
来自康希诺生物的亚洲首个流脑结合疫苗商业化取得巨大突破
來自康希諾生物的亞洲首個流腦結合疫苗商業化取得巨大突破
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575